Bain-backed Kestra Medical jumps 35% in cracking Nasdaq debut

Kestra Medical Technologies

06/03/2025 17:25

Updates

** Shares of medical device maker Kestra Medical Technologies KMTS.O open 35% above the offer price in their Nasdaq debut

** Stock opens at $22.95, compared to the $17 IPO price, giving the Kirkland, Washington-based company a $1.14 billion market cap

** KMTS, backed by buyout firm Bain Capital, sold about 11.9 mln shares in its upsized offering, 19% more than initially offered, and above its marketed range of $14 to $16 apiece to raise $202 mln

** Listing marks first notable March IPO and third medical device maker flotation in New York since October

** KMTS competes in the wearable cardioverter defibrillator market, which has been dominated by Zoll Medical

** BofA Securities, Goldman Sachs and Piper Sandler were the lead bookrunners for the offering

 (Reporting by Arasu Kannagi Basil in Bengaluru)

 ((ArasuKannagi.Basil@thomsonreuters.com;))